ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Senior Research Associate at Revolution Medicines - ApplyBlast

Senior Research Associate

Revolution Medicines

17 days ago

3.5 on Glassdoor

Redwood City, California, United States

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Revolution Medicines is seeking a Senior Research Associate to join the Cell Culture Team and support early discovery programs by generating high-quality cellular materials. This hands-on laboratory role focuses on routine mammalian cell culture, maintaining accurate documentation, and responding to urgent requests to support key program milestones. The position offers opportunities for professional development within a fast-paced, collaborative discovery environment.

Responsibilities

Perform routine mammalian cell culture including expansion and maintenance
Maintain accurate cell line inventory and experimental documentation
Develop protocols and document experimental workflows with high rigor

Skills

Qualifications

S./M.S. degree in Molecular Biology, Cell Biology, Cancer Biology, or related life science field

About Revolution Medicines

revmed.com

Headquarters

Redwood City, California, United States

Company Size

201-500 employees

Founded

2014

View Profile

Revolution Medicines (RevMed) is a biopharmaceutical company dedicated to discovering, developing, and delivering novel targeted medicines for patients with cancer. Their mission focuses specifically on "revolutionizing treatment for patients with RAS‑addicted cancers" through precision-targeted therapies. The company emphasizes a science-driven, end-to-end approach from discovery to delivery. RevMed brands its team as "Revolutionaries" committed to transforming outcomes for people with RAS‑driven tumors.